Table 5

Determinants of visceral obesity in patients with and without hepatitis C virus (HCV) infection

OR (95% CI), per unit increase of parameter
Subgroup/gender/parameterModel 1Model 2
Patients with HCV infection
Men (n=66)
 Body fat per cent1.75 (1.18 to 2.60)**6.11 (1.12 to 33.36)*
 Fat-free mass/BW, ×1000.61 (0.45 to 0.84)**0.38 (0.18 to 0.82)*
 Muscle mass/BW, ×1000.60 (0.43 to 0.84)**0.36 (0.16 to 0.81)*
Women (n=45)
 Body fat per cent1.94 (1.30 to 2.91)**1.98 (1.29 to 3.04)**
 Fat-free mass/BW, ×1000.51 (0.34 to 0.75)**0.48 (0.30 to 0.76)**
 Muscle mass/BW, ×1000.50 (0.34 to 0.75)**0.47 (0.30 to 0.75)**
Patients without HCV infection
Men (n=711)
 Body fat per cent1.78 (1.61 to 1.96)***2.46 (2.04 to 2.97)***
 Fat-free mass/BW, ×1000.58 (0.53 to 0.64)***0.43 (0.36 to 0.52)***
 Muscle mass/BW, ×1000.58 (0.53 to 0.64)***0.43 (0.36 to 0.51)***
Women (n=445)
 Body fat per cent2.17 (1.81 to 2.61)***2.16 (1.78 to 2.61)***
 Fat-free mass/BW, ×1000.49 (0.42 to 0.58)***0.49 (0.41 to 0.59)***
 Muscle mass/BW, ×1000.49 (0.41 to 0.58)***0.48 (0.40 to 0.58)***

  • Model definitions are: Model 1, unadjusted analysis; Model 2, adjusted for age.

  • *p<0.05; **p<0.01; ***p<0.001.

  • BW, body weight.